Summarising published results from spirometric surveys of COPD: The problem of inconsistent definitions

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 8, 2014, Pages 998-1003

  Gupta, Ramyani P ^a,b   Perez Padilla, R ^c   Marks, G ^d,e   Vollmer, W ^f   Menezes, A ^g   Burney, P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Global; Methods; Prevalence; Spirometry

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; SPIROMETRY; SYNDROME DELINEATION; META ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

BRONCHODILATING AGENT;

ADULT; AGED; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 84904550440     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0910     Document Type: Article

References (13)

1. Murray C J L, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012: 380: 2197-2223.
2. Halbert R J, Natoli J L, Gano A, Badamgarav E, Buist A S, Mannino DM. Global burden of COPD: systematic review and meta-analysis. [Review]. Eur Respir J 2006; 28: 523-532. (Pubitemid 44794666)
3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD, USA: GOLD, 2011. www.goldcopd.org.
4. Swanney M P, Ruppel G, Enright P L, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
5. Buist A S, Vollmer W M, Sullivan S D et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005; 2(2): 277-283. (Pubitemid 40993302)
6. Buist A S, McBurnie M A, Vollmer W M, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750. (Pubitemid 47321907)
7. Menezes A M, Perez-Padilla R, Jardim J R, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. [see comment]. Lancet 2005; 366: 1875-1881. (Pubitemid 41690116)
8. Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179.
9. Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310. (Pubitemid 16134762)
10. Vollmer W M, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
11. Mannino D M. Defining chronic obstructive pulmonary disease. . . and the elephant in the room. Eur Respir J 2007; 30: 189-190. (Pubitemid 47194169)
12. Burney P G J, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011; 66: 49-54.
13. Bergendal A, Johansson A°, Bake B, Lötvall J, Skoogh B-E, Löfdahl C-G. Airway effects of salmeterol in healthy individuals. Pulmonary Pharmacol 1995; 8: 283-238.